Vector VestAdvertisement Vector VestAdvertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Amarin Corp. PLC ADS (AMRN)

AMRN RSS Feed
Add AMRN Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Dancing in the dark, go seek, NewMoney, investorfreak69, Biobillionair, HDGabor
Search This Board:
Last Post: 1/25/2015 8:58:22 AM - Followers: 284 - Board type: Free - Posts Today: 14

Amarin Home Page: http://www.amarincorp.com/

Vascepa (icosapent ethyl) Home Page: http://www.vascepa.com/savings.shtml

 

NASDAQ quote: http://www.nasdaq.com/symbol/amrn 

yahoo quote: http://finance.yahoo.com/q/h?s=AMRN 

AMRN company page on SA: http://seekingalpha.com/symbol/amrn?source=search_general&s=amrn


 

VASCEPA prescription spreadsheet: https://docs.google.com/spreadsheet/ccc?key=0AmTJU8mIVSebdGFUY253Y3BsTDBzbWRXSFVjbDZ0bHc#gid=12
Amarin Patent Spreadsheet :https://docs.google.com/spreadsheet/ccc?key=0Av_k_WaYce2IdDRKaWR1TmctcXVnMUhJQnlwbzEzeUE#gid=0

finviz page (headlines and basic stats); http://www.finviz.com/quote.ashx?t=AMRN&ty=c&ta=0&p=d

StreetInsider AMRN data page (headlines and analysts);  http://www.streetinsider.com/stock_lookup.php?LookUp=Get+Quote&q=amrn

 

Investor  Presentation (Apr'2013): http://files.shareholder.com/downloads/AMRN/2410758917x0x651653/CC47C992-CAF5-4A08-8DC6-F1DBF0AD5DB7/Amarin_Investor_Presentation_April_2013.pdf

Investor Presentation (Apr'2012):  http://www.amarincorp.com/downloads/investor-presentation.pdf

Amarin SEC filings: http://investor.amarincorp.com/sec.cfm

Vascepa FDA Orange Book page: http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=202057&Product_No=001&table1=OB_Rx
Vascepa CDER Medical / Clinical Review (July 25, 2012): http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202057Orig1s000MedR.pdf ;


FDA MAPP 5021.1 : http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ManualofPoliciesProcedures/UCM340273.pdf
(MANUAL OF POLICIES AND PROCEDURES, Naming of Drug Products Containing Salt Drug Substances)


~~~~~~~~~~~~~~~~~~~~~~
General:

Good & Bad Cholesterol - http://www.americanheart.org/presenter.jhtml?identifier=180

 

U.S. health system/CDC -  http://uk.reuters.com/article/2011/02/01/us-heart-usa-idUKTRE70N4JD20110201?feedType=RSS&feedName=healthNewsMolt

 

 

~~~~~~~~~~~~~~~~~~~~~~

General: 

The rationale for using EPA http://www.drsears.com/Portals/6/Documents/Understanding%20Eicosanoids.pdf 

 

Marine Trial hits all EndPoints - http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=533361

Marine Trial Conf Call (Nov '10):  - http://www.investorcalendar.com/IC/CEPage.asp?ID=162661

Transcript MARINE trial CC: http://files.shareholder.com/downloads/AMRN/1080589559x0x430674/E6D77DA6-F44C-405F-B479-9A5C31E7A6E3/AmarinCorporation112910_Transcript.pdf

Marine Trial Presentation - http://files.shareholder.com/downloads/AMRN/1080589559x0x423194/424D45B3-62CC-4A84-81D7-F5264EF82A11/MARINE_RESULTS_Nov_29_2010.pdf

Anchor Trial completes Enrollment - http://files.shareholder.com/downloads/AMRN/1080589559x0x428546/275b9676-c0cf-4bd0-a69b-e80e26433822/AMRN_News_2010_12_16_General_Releases.pdf

Anchor Trial hits all EndPoints - http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=569648

Anchor Trial Conf Call (Apr '11):  http://www.investorcalendar.com/IC/CEPage.asp?ID=164219

Additional Marine Trial Results:       http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=579260

 

Lovaza Label, etc

 

Excellent Blog Article featuring Lovaza data comparison - http://www.chasingthealpha.com/2010/11/amrn-look-at-tg-and-ldl-levels.html

 

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-654_Omacor.cfm

 

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021853_021654s016_omacor_toc.cfm

 

 

Various Trials, Statins/Lovaza etc:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813819/pdf/mayoclinproc_85_2_004.pdf

http://www.ncbi.nlm.nih.gov/pubmed/20877395

 

http://www.ncbi.nlm.nih.gov/pubmed/19002433

 

http://www.ncbi.nlm.nih.gov/pubmed/15250255

 

TriCor label, FIELD trial - http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021656s019lbl.pdf  

ACCORD trial - http://www.endocrinetoday.com/view.aspx?rid=61934 

                                                                    

Jelis Trial (Japan) - http://www.ccmdweb.org/dsl/middle.aspx?Slideid=2643&Catid=1043

transcript, ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE, 10/16/2013: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM376102.pdf
 




GOOGLE SPREADSHEET REGARDING PATENTS:
https://accounts.google.com/ServiceLogin?service=wise&passive=1209600&continue=https%3A%2F%2Fdocs.google.com%2Fspreadsheet%2Fccc%3Fkey%3D0Av_k_WaYce2IdDRKaWR1TmctcXVnMUhJQnlwbzEzeUE&followup=https%3A%2F%2Fdocs.google.com%2Fspreadsheet%2Fccc%3Fkey%3D0Av_k_WaYce2IdDRKaWR1TmctcXVnMUhJQnlwbzEzeUE&authuser=0#gid=0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMRN
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for AMRN
AMRN News: Current Report Filing (8-k) 01/12/2015 08:01:49 AM
AMRN News: Statement of Ownership (sc 13g) 11/19/2014 02:58:27 PM
AMRN News: Current Report Filing (8-k) 11/14/2014 04:43:57 PM
AMRN News: Quarterly Report (10-q) 11/06/2014 04:06:13 PM
AMRN News: Current Report Filing (8-k) 11/06/2014 04:02:46 PM
PostSubject
#40844  Sticky Note Complaint to HHS requesting compensatory damages: Biobillionair 01/13/15 01:13:11 PM
#30568  Sticky Note WRITE CONGRESS... WRITE THE FDA TODAY!!! go seek 07/11/14 07:31:47 PM
#4704  Sticky Note Everyone, Please get back on topic about AMRN, only. IH Admin [Linda] 04/22/13 09:21:30 AM
#41320   AMRN has stated they want to make it couldbebetter 01/25/15 08:58:22 AM
#41319   The other factor in reduced visibility to V zumantu 01/25/15 08:29:01 AM
#41318   Zip, my sources telling me Kowa reps ineffective, zumantu 01/25/15 08:22:38 AM
#41317   sts66, I agree, EPA sourcing could become an zumantu 01/25/15 08:07:32 AM
#41316   Ahab stick to the white whale analogies please Bad_Advice 01/25/15 07:55:47 AM
#41315   EPADI CP---something odd is going down, possible Biobillionair 01/25/15 07:41:46 AM
#41314   Most people can handle a 4 grams a BioChica 01/25/15 07:24:11 AM
#41313   Data leaked hours/days before pubic release, is a BioChica 01/25/15 07:15:21 AM
#41312   EPA is a simple molecule, EPA derived from BioChica 01/25/15 07:08:19 AM
#41311   And if BP refuses to pay what AMRN me33 01/25/15 06:33:15 AM
#41310   AMRN dose not want a BP partner...I believe couldbebetter 01/25/15 12:51:28 AM
#41309   Sounds like you have a smart doc! couldbebetter 01/25/15 12:47:54 AM
#41308   The side affect I am aware of is couldbebetter 01/25/15 12:37:47 AM
#41307   Hi HD Whalatane 01/25/15 12:03:06 AM
#41306   Low plasma EPA concentration as a possible risk zumantu 01/24/15 11:44:09 PM
#41305   the ?-3 17,18-epoxide of eicosapentaenoic acid activates anti-proliferative zumantu 01/24/15 11:34:59 PM
#41304   Steve The stone has left the sling and is Biobillionair 01/24/15 10:38:01 PM
#41303   ...This becomes a David & Goliath story. The steve2014 01/24/15 09:54:55 PM
#41302   That is why I am long the stock. rosemountbomber 01/24/15 07:43:11 PM
#41301   JL...you still out there Doc?.......BTW....to the rest of epenephrine 01/24/15 06:26:23 PM
#41300   Ditto that. I too am a rube MontanaState83 01/24/15 06:20:11 PM
#41299   Why don't you enlighten us? MontanaState83 01/24/15 06:16:28 PM
#41298   Look at it a different way - think sts66 01/24/15 03:46:43 PM
#41297   I think JL stated that patients should not sts66 01/24/15 03:43:37 PM
#41296   Obviously the largest part of the market does sts66 01/24/15 03:37:16 PM
#41295   The biggest problem we may have, were are sts66 01/24/15 03:31:05 PM
#41294   There's been plenty of data leaks over the sts66 01/24/15 03:24:27 PM
#41293   I was far away again. HDGabor 01/24/15 03:20:25 PM
#41292   Invest ..yes there have been cases ...recently Cohen's Whalatane 01/24/15 12:51:40 PM
#41291   Couldbebetter Vascepa is dose dependent ....no one is being Whalatane 01/24/15 12:43:21 PM
#41290   EPA and intracerebral hemorrhage rdhitchcock 01/24/15 11:47:53 AM
#41289   Agree. I use JELIS as a confirmation of HDGabor 01/24/15 11:41:25 AM
#41288   I agree...but when your success hinges on the Biobillionair 01/24/15 10:41:24 AM
#41287   Rosemount--- There will be no slow rise in Amarin Biobillionair 01/24/15 10:38:47 AM
#41286   Companies that conduct such studies would be greatly Biobillionair 01/24/15 10:32:53 AM
#41285   Kowa did not agree to market Vascepa for ziploc_1 01/24/15 10:13:14 AM
#41284   The JELIS study shows EPA has beneficial results couldbebetter 01/24/15 09:01:23 AM
#41283   I may be a rube when it comes invest2992 01/24/15 08:44:21 AM
#41282   No doubt EPA at the right dose does couldbebetter 01/24/15 08:37:48 AM
#41281   As some posters have already noted in response rosemountbomber 01/24/15 06:25:09 AM
#41280   I believe that Vascepa market, may be larger BioChica 01/24/15 05:31:28 AM
#41279   Who would leak such data? BioChica 01/24/15 05:19:53 AM
#41278   January 21, 2015 Biobillionair 01/23/15 11:03:43 PM
#41277   Your speculation on study results being negative because L0tsaluck2000 01/23/15 11:02:49 PM
#41276   It may take 1 - 3 years before couldbebetter 01/23/15 10:20:22 PM
#41275   thank you sir, for your post concerning, the 1bill 01/23/15 09:45:36 PM
#41274   If Vascepa is as good as many of invest2992 01/23/15 09:04:59 PM
#41273   excellent, excellent, very concrete, concerning our amrn corp, 1bill 01/23/15 08:50:41 PM
#41272   High regard? You haven't seen my John Jenkins bidmark 01/23/15 04:05:35 PM
#41271   You missed this enrollment number change! They went BioChica 01/23/15 04:04:49 PM
PostSubject